Movatterモバイル変換

[0]ホーム
URL:

Jump to content
WikipediaThe Free Encyclopedia
Search

16-Ketoestradiol

From Wikipedia, the free encyclopedia
16-Ketoestradiol
Names
IUPAC name
3,17β-Dihydroxyestra-1,3,5(10)-trien-16-one
Systematic IUPAC name
(1R,3aS,3bR,9bS,11aS)-1,7-Dihydroxy-11a-methyl-1,3,3a,3b,4,5,9b,10,11,11a-decahydro-2H-cyclopenta[a]phenanthren-2-one
Other names
17-Oxoestradiol; 17-Oxo-estradiol; 17-Keto-E2; 17-Oxo-E2; 16-Oxo-estra-1,3,5(10)-trien-3,17β-diol; NSC-51169
Identifiers
3D model (JSmol)
ChEBI
ChEMBL
ChemSpider
KEGG
UNII
  • InChI=1S/C18H22O3/c1-18-7-6-13-12-5-3-11(19)8-10(12)2-4-14(13)15(18)9-16(20)17(18)21/h3,5,8,13-15,17,19,21H,2,4,6-7,9H2,1H3/t13-,14-,15+,17+,18+/m1/s1
    Key: KJDGFQJCHFJTRH-YONAWACDSA-N
  • C[C@]12CC[C@H]3[C@H]([C@@H]1CC(=O)[C@@H]2O)CCC4=C3C=CC(=C4)O
Properties
C18H22O3
Molar mass286.371 g·mol−1
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa).
Chemical compound

16-Ketoestradiol (16-keto-E2,16-oxoestradiol, or16-oxo-E2) is anendogenousestrogen related to16-ketoestrone.[1][2][3] 16-Ketoestrone is a very weak estrogen with only 1/1000 theestrogenicpotency ofestradiol in theuterus.[3] It is a so-called "short-acting" or "impeded" estrogen, similarly toestriol anddimethylstilbestrol.[4][5][6][7][8]

See also

[edit]

References

[edit]
  1. ^"Human Metabolome Database: Showing metabocard for 16-Ketoestradiol (HMDB0000406)".
  2. ^Breuer, Heinz (1962).The Metabolism of the Natural Estrogens. Vitamins & Hormones. Vol. 20. pp. 285–335.doi:10.1016/S0083-6729(08)60720-7.ISBN 9780127098203.ISSN 0083-6729.{{cite book}}:ISBN / Date incompatibility (help)
  3. ^abHuggins C, Jensen EV (September 1955)."The depression of estrone-induced uterine growth by phenolic estrogens with oxygenated functions at positions 6 or 16: the impeded estrogens".J. Exp. Med.102 (3):335–46.doi:10.1084/jem.102.3.335.PMC 2136510.PMID 13252187.
  4. ^Clark JH, Paszko Z, Peck EJ (January 1977). "Nuclear binding and retention of the receptor estrogen complex: relation to the agonistic and antagonistic properties of estriol".Endocrinology.100 (1):91–6.doi:10.1210/endo-100-1-91.PMID 830547.
  5. ^Clark JH, Hardin JW, McCormack SA (1979). "Mechanism of action of estrogen agonists and antagonists".J. Anim. Sci.49 (Suppl 2):46–65.doi:10.1093/ansci/49.supplement_ii.46.PMID 400777.
  6. ^Lunan CB, Klopper A (September 1975)."Antioestrogens. A review".Clin. Endocrinol. (Oxf).4 (5):551–72.doi:10.1111/j.1365-2265.1975.tb01568.x.PMID 170029.S2CID 9628572.
  7. ^Clark JH, Markaverich BM (1983). "The agonistic and antagonistic effects of short acting estrogens: a review".Pharmacol. Ther.21 (3):429–53.doi:10.1016/0163-7258(83)90063-3.PMID 6356176.
  8. ^Clark JH, Markaverich BM (April 1984). "The agonistic and antagonistic actions of estriol".J. Steroid Biochem.20 (4B):1005–13.doi:10.1016/0022-4731(84)90011-6.PMID 6202959.
Precursors
Corticosteroids
Glucocorticoids
Mineralocorticoids
Sex steroids
Androgens
Estrogens
Progestogens
Neurosteroids
Others
ERTooltip Estrogen receptor
Agonists
Mixed
(SERMsTooltip Selective estrogen receptor modulators)
Antagonists
GPERTooltip G protein-coupled estrogen receptor
Agonists
Antagonists
Unknown


This article about anestrane is astub. You can help Wikipedia byexpanding it.

Stub icon

Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=16-Ketoestradiol&oldid=1308581283"
Categories:
Hidden categories:
[8]ページ先頭
©2009-2025 Movatter.jp